The global Spatial Transcriptomics Service market is projected to grow from US$ 2276 million in 2024 to US$ 4746 million by 2031, at a CAGR of 11.2% (2025-2031), driven by critical product segments and diverse end‑use applications.

Spatial Transcriptomics Service Market

Spatial Transcriptomics is the ability to capture the positional context of transcriptional activity within intact tissue, either for regions or single cells. It defines an array of technologies enabling researchers to locate transcripts, often down to the subcellular level, providing an unbiased map of RNA molecules throughout tissue sections.These techniques often employ microscopy and next-generation sequencing to empower scientists to measure gene expression within a specific tissue or cellular context.

From a downstream perspective, Pathology accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Spatial Transcriptomics Service leading manufacturers including CD Genomics, Single Cell Discoveries BV, AcelaBio, SciLifeLab, SeqMatic LLC, Firalis Molecular Precision, Indivumed Services, Creative Biolabs, Macrogen Europe, Molecular Genomics Pte Ltd., etc., dominate supply; the top five capture approximately % of global revenue, with CD Genomics leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Spatial Transcriptomics Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Spatial Transcriptomics Service Market Report

Report Metric	Details
Report Name	Spatial Transcriptomics Service Market
Accounted market size in 2024	US$ 2276 million
Forecasted market size in 2031	US$ 4746 million
CAGR	11.2%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	10x Genomics Visium Based Nanostring Based Vizgen MERSCOPE Based Other
Segment by Application	Pathology Immunology Developmental Biology Oncology Neuroscience Other
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CD Genomics, Single Cell Discoveries BV, AcelaBio, SciLifeLab, SeqMatic LLC, Firalis Molecular Precision, Indivumed Services, Creative Biolabs, Macrogen Europe, Molecular Genomics Pte Ltd., OBiO Technology ( Shanghai ) Corp.,Ltd., BGI Genomics, Dynamic-biosystems, TianGen, Novogene, Beijing Sun-Novo Pharmaceutical Research (Novopathway), Shanghai Novelbio Medical Tech, Singleron Biotechnologies, SHANGHAI OE Biotech, Gene Denovo
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Spatial Transcriptomics Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Spatial Transcriptomics Service Market growing?

Ans: The Spatial Transcriptomics Service Market witnessing a CAGR of 11.2% during the forecast period 2025-2031.

What is the Spatial Transcriptomics Service Market size in 2031?

Ans: The Spatial Transcriptomics Service Market size in 2031 will be US$ 4746 million.

Who are the main players in the Spatial Transcriptomics Service Market report?

Ans: The main players in the Spatial Transcriptomics Service Market are CD Genomics, Single Cell Discoveries BV, AcelaBio, SciLifeLab, SeqMatic LLC, Firalis Molecular Precision, Indivumed Services, Creative Biolabs, Macrogen Europe, Molecular Genomics Pte Ltd., OBiO Technology ( Shanghai ) Corp.,Ltd., BGI Genomics, Dynamic-biosystems, TianGen, Novogene, Beijing Sun-Novo Pharmaceutical Research (Novopathway), Shanghai Novelbio Medical Tech, Singleron Biotechnologies, SHANGHAI OE Biotech, Gene Denovo

What are the Application segmentation covered in the Spatial Transcriptomics Service Market report?

Ans: The Applications covered in the Spatial Transcriptomics Service Market report are Pathology, Immunology, Developmental Biology, Oncology, Neuroscience, Other

What are the Type segmentation covered in the Spatial Transcriptomics Service Market report?

Ans: The Types covered in the Spatial Transcriptomics Service Market report are 10x Genomics Visium Based, Nanostring Based, Vizgen MERSCOPE Based, Other

1 Study Coverage

1.1 Introduction to Spatial Transcriptomics Service: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Spatial Transcriptomics Service Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 10x Genomics Visium Based

1.2.3 Nanostring Based

1.2.4 Vizgen MERSCOPE Based

1.2.5 Other

1.3 Market Segmentation by Application

1.3.1 Global Spatial Transcriptomics Service Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Pathology

1.3.3 Immunology

1.3.4 Developmental Biology

1.3.5 Oncology

1.3.6 Neuroscience

1.3.7 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Spatial Transcriptomics Service Revenue Estimates and Forecasts 2020-2031

2.2 Global Spatial Transcriptomics Service Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global Spatial Transcriptomics Service Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Spatial Transcriptomics Service Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 10x Genomics Visium Based Market Size by Players

3.3.2 Nanostring Based Market Size by Players

3.3.3 Vizgen MERSCOPE Based Market Size by Players

3.3.4 Other Market Size by Players

3.4 Global Spatial Transcriptomics Service Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Spatial Transcriptomics Service Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Spatial Transcriptomics Service Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Spatial Transcriptomics Service Market Size by Type (2020-2031)

6.4 North America Spatial Transcriptomics Service Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Spatial Transcriptomics Service Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Spatial Transcriptomics Service Market Size by Type (2020-2031)

7.4 Europe Spatial Transcriptomics Service Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Spatial Transcriptomics Service Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Spatial Transcriptomics Service Market Size by Type (2020-2031)

8.4 Asia-Pacific Spatial Transcriptomics Service Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Spatial Transcriptomics Service Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Spatial Transcriptomics Service Market Size by Type (2020-2031)

9.4 Central and South America Spatial Transcriptomics Service Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Spatial Transcriptomics Service Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Spatial Transcriptomics Service Market Size by Type (2020-2031)

10.4 Middle East and Africa Spatial Transcriptomics Service Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Spatial Transcriptomics Service Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 CD Genomics

11.1.1 CD Genomics Corporation Information

11.1.2 CD Genomics Business Overview

11.1.3 CD Genomics Spatial Transcriptomics Service Product Features and Attributes

11.1.4 CD Genomics Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.1.5 CD Genomics Spatial Transcriptomics Service Revenue by Product in 2024

11.1.6 CD Genomics Spatial Transcriptomics Service Revenue by Application in 2024

11.1.7 CD Genomics Spatial Transcriptomics Service Revenue by Geographic Area in 2024

11.1.8 CD Genomics Spatial Transcriptomics Service SWOT Analysis

11.1.9 CD Genomics Recent Developments

11.2 Single Cell Discoveries BV

11.2.1 Single Cell Discoveries BV Corporation Information

11.2.2 Single Cell Discoveries BV Business Overview

11.2.3 Single Cell Discoveries BV Spatial Transcriptomics Service Product Features and Attributes

11.2.4 Single Cell Discoveries BV Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.2.5 Single Cell Discoveries BV Spatial Transcriptomics Service Revenue by Product in 2024

11.2.6 Single Cell Discoveries BV Spatial Transcriptomics Service Revenue by Application in 2024

11.2.7 Single Cell Discoveries BV Spatial Transcriptomics Service Revenue by Geographic Area in 2024

11.2.8 Single Cell Discoveries BV Spatial Transcriptomics Service SWOT Analysis

11.2.9 Single Cell Discoveries BV Recent Developments

11.3 AcelaBio

11.3.1 AcelaBio Corporation Information

11.3.2 AcelaBio Business Overview

11.3.3 AcelaBio Spatial Transcriptomics Service Product Features and Attributes

11.3.4 AcelaBio Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.3.5 AcelaBio Spatial Transcriptomics Service Revenue by Product in 2024

11.3.6 AcelaBio Spatial Transcriptomics Service Revenue by Application in 2024

11.3.7 AcelaBio Spatial Transcriptomics Service Revenue by Geographic Area in 2024

11.3.8 AcelaBio Spatial Transcriptomics Service SWOT Analysis

11.3.9 AcelaBio Recent Developments

11.4 SciLifeLab

11.4.1 SciLifeLab Corporation Information

11.4.2 SciLifeLab Business Overview

11.4.3 SciLifeLab Spatial Transcriptomics Service Product Features and Attributes

11.4.4 SciLifeLab Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.4.5 SciLifeLab Spatial Transcriptomics Service Revenue by Product in 2024

11.4.6 SciLifeLab Spatial Transcriptomics Service Revenue by Application in 2024

11.4.7 SciLifeLab Spatial Transcriptomics Service Revenue by Geographic Area in 2024

11.4.8 SciLifeLab Spatial Transcriptomics Service SWOT Analysis

11.4.9 SciLifeLab Recent Developments

11.5 SeqMatic LLC

11.5.1 SeqMatic LLC Corporation Information

11.5.2 SeqMatic LLC Business Overview

11.5.3 SeqMatic LLC Spatial Transcriptomics Service Product Features and Attributes

11.5.4 SeqMatic LLC Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.5.5 SeqMatic LLC Spatial Transcriptomics Service Revenue by Product in 2024

11.5.6 SeqMatic LLC Spatial Transcriptomics Service Revenue by Application in 2024

11.5.7 SeqMatic LLC Spatial Transcriptomics Service Revenue by Geographic Area in 2024

11.5.8 SeqMatic LLC Spatial Transcriptomics Service SWOT Analysis

11.5.9 SeqMatic LLC Recent Developments

11.6 Firalis Molecular Precision

11.6.1 Firalis Molecular Precision Corporation Information

11.6.2 Firalis Molecular Precision Business Overview

11.6.3 Firalis Molecular Precision Spatial Transcriptomics Service Product Features and Attributes

11.6.4 Firalis Molecular Precision Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.6.5 Firalis Molecular Precision Recent Developments

11.7 Indivumed Services

11.7.1 Indivumed Services Corporation Information

11.7.2 Indivumed Services Business Overview

11.7.3 Indivumed Services Spatial Transcriptomics Service Product Features and Attributes

11.7.4 Indivumed Services Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.7.5 Indivumed Services Recent Developments

11.8 Creative Biolabs

11.8.1 Creative Biolabs Corporation Information

11.8.2 Creative Biolabs Business Overview

11.8.3 Creative Biolabs Spatial Transcriptomics Service Product Features and Attributes

11.8.4 Creative Biolabs Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.8.5 Creative Biolabs Recent Developments

11.9 Macrogen Europe

11.9.1 Macrogen Europe Corporation Information

11.9.2 Macrogen Europe Business Overview

11.9.3 Macrogen Europe Spatial Transcriptomics Service Product Features and Attributes

11.9.4 Macrogen Europe Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.9.5 Macrogen Europe Recent Developments

11.10 Molecular Genomics Pte Ltd.

11.10.1 Molecular Genomics Pte Ltd. Corporation Information

11.10.2 Molecular Genomics Pte Ltd. Business Overview

11.10.3 Molecular Genomics Pte Ltd. Spatial Transcriptomics Service Product Features and Attributes

11.10.4 Molecular Genomics Pte Ltd. Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 OBiO Technology ( Shanghai ) Corp.,Ltd.

11.11.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Corporation Information

11.11.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview

11.11.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Spatial Transcriptomics Service Product Features and Attributes

11.11.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.11.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Developments

11.12 BGI Genomics

11.12.1 BGI Genomics Corporation Information

11.12.2 BGI Genomics Business Overview

11.12.3 BGI Genomics Spatial Transcriptomics Service Product Features and Attributes

11.12.4 BGI Genomics Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.12.5 BGI Genomics Recent Developments

11.13 Dynamic-biosystems

11.13.1 Dynamic-biosystems Corporation Information

11.13.2 Dynamic-biosystems Business Overview

11.13.3 Dynamic-biosystems Spatial Transcriptomics Service Product Features and Attributes

11.13.4 Dynamic-biosystems Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.13.5 Dynamic-biosystems Recent Developments

11.14 TianGen

11.14.1 TianGen Corporation Information

11.14.2 TianGen Business Overview

11.14.3 TianGen Spatial Transcriptomics Service Product Features and Attributes

11.14.4 TianGen Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.14.5 TianGen Recent Developments

11.15 Novogene

11.15.1 Novogene Corporation Information

11.15.2 Novogene Business Overview

11.15.3 Novogene Spatial Transcriptomics Service Product Features and Attributes

11.15.4 Novogene Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.15.5 Novogene Recent Developments

11.16 Beijing Sun-Novo Pharmaceutical Research (Novopathway)

11.16.1 Beijing Sun-Novo Pharmaceutical Research (Novopathway) Corporation Information

11.16.2 Beijing Sun-Novo Pharmaceutical Research (Novopathway) Business Overview

11.16.3 Beijing Sun-Novo Pharmaceutical Research (Novopathway) Spatial Transcriptomics Service Product Features and Attributes

11.16.4 Beijing Sun-Novo Pharmaceutical Research (Novopathway) Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.16.5 Beijing Sun-Novo Pharmaceutical Research (Novopathway) Recent Developments

11.17 Shanghai Novelbio Medical Tech

11.17.1 Shanghai Novelbio Medical Tech Corporation Information

11.17.2 Shanghai Novelbio Medical Tech Business Overview

11.17.3 Shanghai Novelbio Medical Tech Spatial Transcriptomics Service Product Features and Attributes

11.17.4 Shanghai Novelbio Medical Tech Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.17.5 Shanghai Novelbio Medical Tech Recent Developments

11.18 Singleron Biotechnologies

11.18.1 Singleron Biotechnologies Corporation Information

11.18.2 Singleron Biotechnologies Business Overview

11.18.3 Singleron Biotechnologies Spatial Transcriptomics Service Product Features and Attributes

11.18.4 Singleron Biotechnologies Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.18.5 Singleron Biotechnologies Recent Developments

11.19 SHANGHAI OE Biotech

11.19.1 SHANGHAI OE Biotech Corporation Information

11.19.2 SHANGHAI OE Biotech Business Overview

11.19.3 SHANGHAI OE Biotech Spatial Transcriptomics Service Product Features and Attributes

11.19.4 SHANGHAI OE Biotech Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.19.5 SHANGHAI OE Biotech Recent Developments

11.20 Gene Denovo

11.20.1 Gene Denovo Corporation Information

11.20.2 Gene Denovo Business Overview

11.20.3 Gene Denovo Spatial Transcriptomics Service Product Features and Attributes

11.20.4 Gene Denovo Spatial Transcriptomics Service Revenue and Gross Margin (2020-2025)

11.20.5 Gene Denovo Recent Developments

12 Spatial Transcriptomics ServiceIndustry Chain Analysis

12.1 Spatial Transcriptomics Service Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Spatial Transcriptomics Service Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Spatial Transcriptomics Service Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

CD Genomics

SciLifeLab

SeqMatic LLC

Firalis Molecular Precision

Creative-Biolabs

Macrogen Europe

OBiO Technology ( Shanghai ) Corp.,Ltd.

Singleron Biotechnologies

Shanghai OE Biotech

Gene Denovo

Single Cell Discoveries BV

AcelaBio

Molecular Genomics Pte Ltd.

Beijing Sun-Novo Pharmaceutical Research (Novopathway)

Shanghai Novelbio Medical Tech

List of Tables

Table 1. Global Spatial Transcriptomics Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Spatial Transcriptomics Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Spatial Transcriptomics Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Spatial Transcriptomics Service Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Spatial Transcriptomics Service Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global Spatial Transcriptomics Service Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global Spatial Transcriptomics Service Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global Spatial Transcriptomics Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spatial Transcriptomics Service as of 2024)

Table 11. Global Spatial Transcriptomics Service Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global Spatial Transcriptomics Service Companies Headquarters

Table 13. Global Spatial Transcriptomics Service Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global Spatial Transcriptomics Service Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global Spatial Transcriptomics Service Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global Spatial Transcriptomics Service Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global Spatial Transcriptomics Service Revenue by Application (2026-2031) & (US$ Million)

Table 21. Spatial Transcriptomics Service High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America Spatial Transcriptomics Service Growth Accelerators and Market Barriers

Table 25. North America Spatial Transcriptomics Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe Spatial Transcriptomics Service Growth Accelerators and Market Barriers

Table 27. Europe Spatial Transcriptomics Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific Spatial Transcriptomics Service Growth Accelerators and Market Barriers

Table 29. Asia-Pacific Spatial Transcriptomics Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America Spatial Transcriptomics Service Investment Opportunities and Key Challenges

Table 31. Central and South America Spatial Transcriptomics Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa Spatial Transcriptomics Service Investment Opportunities and Key Challenges

Table 33. Middle East and Africa Spatial Transcriptomics Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. CD Genomics Corporation Information

Table 35. CD Genomics Description and Major Businesses

Table 36. CD Genomics Product Features and Attributes

Table 37. CD Genomics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. CD Genomics Revenue Proportion by Product in 2024

Table 39. CD Genomics Revenue Proportion by Application in 2024

Table 40. CD Genomics Revenue Proportion by Geographic Area in 2024

Table 41. CD Genomics Spatial Transcriptomics Service SWOT Analysis

Table 42. CD Genomics Recent Developments

Table 43. Single Cell Discoveries BV Corporation Information

Table 44. Single Cell Discoveries BV Description and Major Businesses

Table 45. Single Cell Discoveries BV Product Features and Attributes

Table 46. Single Cell Discoveries BV Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Single Cell Discoveries BV Revenue Proportion by Product in 2024

Table 48. Single Cell Discoveries BV Revenue Proportion by Application in 2024

Table 49. Single Cell Discoveries BV Revenue Proportion by Geographic Area in 2024

Table 50. Single Cell Discoveries BV Spatial Transcriptomics Service SWOT Analysis

Table 51. Single Cell Discoveries BV Recent Developments

Table 52. AcelaBio Corporation Information

Table 53. AcelaBio Description and Major Businesses

Table 54. AcelaBio Product Features and Attributes

Table 55. AcelaBio Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. AcelaBio Revenue Proportion by Product in 2024

Table 57. AcelaBio Revenue Proportion by Application in 2024

Table 58. AcelaBio Revenue Proportion by Geographic Area in 2024

Table 59. AcelaBio Spatial Transcriptomics Service SWOT Analysis

Table 60. AcelaBio Recent Developments

Table 61. SciLifeLab Corporation Information

Table 62. SciLifeLab Description and Major Businesses

Table 63. SciLifeLab Product Features and Attributes

Table 64. SciLifeLab Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. SciLifeLab Revenue Proportion by Product in 2024

Table 66. SciLifeLab Revenue Proportion by Application in 2024

Table 67. SciLifeLab Revenue Proportion by Geographic Area in 2024

Table 68. SciLifeLab Spatial Transcriptomics Service SWOT Analysis

Table 69. SciLifeLab Recent Developments

Table 70. SeqMatic LLC Corporation Information

Table 71. SeqMatic LLC Description and Major Businesses

Table 72. SeqMatic LLC Product Features and Attributes

Table 73. SeqMatic LLC Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. SeqMatic LLC Revenue Proportion by Product in 2024

Table 75. SeqMatic LLC Revenue Proportion by Application in 2024

Table 76. SeqMatic LLC Revenue Proportion by Geographic Area in 2024

Table 77. SeqMatic LLC Spatial Transcriptomics Service SWOT Analysis

Table 78. SeqMatic LLC Recent Developments

Table 79. Firalis Molecular Precision Corporation Information

Table 80. Firalis Molecular Precision Description and Major Businesses

Table 81. Firalis Molecular Precision Product Features and Attributes

Table 82. Firalis Molecular Precision Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. Firalis Molecular Precision Recent Developments

Table 84. Indivumed Services Corporation Information

Table 85. Indivumed Services Description and Major Businesses

Table 86. Indivumed Services Product Features and Attributes

Table 87. Indivumed Services Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. Indivumed Services Recent Developments

Table 89. Creative Biolabs Corporation Information

Table 90. Creative Biolabs Description and Major Businesses

Table 91. Creative Biolabs Product Features and Attributes

Table 92. Creative Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. Creative Biolabs Recent Developments

Table 94. Macrogen Europe Corporation Information

Table 95. Macrogen Europe Description and Major Businesses

Table 96. Macrogen Europe Product Features and Attributes

Table 97. Macrogen Europe Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. Macrogen Europe Recent Developments

Table 99. Molecular Genomics Pte Ltd. Corporation Information

Table 100. Molecular Genomics Pte Ltd. Description and Major Businesses

Table 101. Molecular Genomics Pte Ltd. Product Features and Attributes

Table 102. Molecular Genomics Pte Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. Molecular Genomics Pte Ltd. Recent Developments

Table 104. OBiO Technology ( Shanghai ) Corp.,Ltd. Corporation Information

Table 105. OBiO Technology ( Shanghai ) Corp.,Ltd. Description and Major Businesses

Table 106. OBiO Technology ( Shanghai ) Corp.,Ltd. Product Features and Attributes

Table 107. OBiO Technology ( Shanghai ) Corp.,Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 108. OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Developments

Table 109. BGI Genomics Corporation Information

Table 110. BGI Genomics Description and Major Businesses

Table 111. BGI Genomics Product Features and Attributes

Table 112. BGI Genomics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 113. BGI Genomics Recent Developments

Table 114. Dynamic-biosystems Corporation Information

Table 115. Dynamic-biosystems Description and Major Businesses

Table 116. Dynamic-biosystems Product Features and Attributes

Table 117. Dynamic-biosystems Revenue (US$ Million) and Gross Margin (2020-2025)

Table 118. Dynamic-biosystems Recent Developments

Table 119. TianGen Corporation Information

Table 120. TianGen Description and Major Businesses

Table 121. TianGen Product Features and Attributes

Table 122. TianGen Revenue (US$ Million) and Gross Margin (2020-2025)

Table 123. TianGen Recent Developments

Table 124. Novogene Corporation Information

Table 125. Novogene Description and Major Businesses

Table 126. Novogene Product Features and Attributes

Table 127. Novogene Revenue (US$ Million) and Gross Margin (2020-2025)

Table 128. Novogene Recent Developments

Table 129. Beijing Sun-Novo Pharmaceutical Research (Novopathway) Corporation Information

Table 130. Beijing Sun-Novo Pharmaceutical Research (Novopathway) Description and Major Businesses

Table 131. Beijing Sun-Novo Pharmaceutical Research (Novopathway) Product Features and Attributes

Table 132. Beijing Sun-Novo Pharmaceutical Research (Novopathway) Revenue (US$ Million) and Gross Margin (2020-2025)

Table 133. Beijing Sun-Novo Pharmaceutical Research (Novopathway) Recent Developments

Table 134. Shanghai Novelbio Medical Tech Corporation Information

Table 135. Shanghai Novelbio Medical Tech Description and Major Businesses

Table 136. Shanghai Novelbio Medical Tech Product Features and Attributes

Table 137. Shanghai Novelbio Medical Tech Revenue (US$ Million) and Gross Margin (2020-2025)

Table 138. Shanghai Novelbio Medical Tech Recent Developments

Table 139. Singleron Biotechnologies Corporation Information

Table 140. Singleron Biotechnologies Description and Major Businesses

Table 141. Singleron Biotechnologies Product Features and Attributes

Table 142. Singleron Biotechnologies Revenue (US$ Million) and Gross Margin (2020-2025)

Table 143. Singleron Biotechnologies Recent Developments

Table 144. SHANGHAI OE Biotech Corporation Information

Table 145. SHANGHAI OE Biotech Description and Major Businesses

Table 146. SHANGHAI OE Biotech Product Features and Attributes

Table 147. SHANGHAI OE Biotech Revenue (US$ Million) and Gross Margin (2020-2025)

Table 148. SHANGHAI OE Biotech Recent Developments

Table 149. Gene Denovo Corporation Information

Table 150. Gene Denovo Description and Major Businesses

Table 151. Gene Denovo Product Features and Attributes

Table 152. Gene Denovo Revenue (US$ Million) and Gross Margin (2020-2025)

Table 153. Gene Denovo Recent Developments

Table 154. Raw Materials Key Suppliers

Table 155. Distributors List

Table 156. Market Trends and Market Evolution

Table 157. Market Drivers and Opportunities

Table 158. Market Challenges, Risks, and Restraints

Table 159. Research Programs/Design for This Report

Table 160. Key Data Information from Secondary Sources

Table 161. Key Data Information from Primary Sources

List of Figures

Figure 1. Spatial Transcriptomics Service Product Picture

Figure 2. Global Spatial Transcriptomics Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. 10x Genomics Visium Based Product Picture

Figure 4. Nanostring Based Product Picture

Figure 5. Vizgen MERSCOPE Based Product Picture

Figure 6. Other Product Picture

Figure 7. Global Spatial Transcriptomics Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Pathology

Figure 9. Immunology

Figure 10. Developmental Biology

Figure 11. Oncology

Figure 12. Neuroscience

Figure 13. Other

Figure 14. Spatial Transcriptomics Service Report Years Considered

Figure 15. Global Spatial Transcriptomics Service Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 17. Global Spatial Transcriptomics Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 18. Global Spatial Transcriptomics Service Revenue Market Share by Region (2020-2031)

Figure 19. Global Spatial Transcriptomics Service Revenue Market Share Ranking (2024)

Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 21. 10x Genomics Visium Based Revenue Market Share by Player in 2024

Figure 22. Nanostring Based Revenue Market Share by Player in 2024

Figure 23. Vizgen MERSCOPE Based Revenue Market Share by Player in 2024

Figure 24. Other Revenue Market Share by Player in 2024

Figure 25. Global Spatial Transcriptomics Service Revenue Market Share by Type (2020-2031)

Figure 26. Global Spatial Transcriptomics Service Revenue Market Share by Application (2020-2031)

Figure 27. North America Spatial Transcriptomics Service Revenue YoY (2020-2031) & (US$ Million)

Figure 28. North America Top 5 Players Spatial Transcriptomics Service Revenue (US$ Million) in 2024

Figure 29. North America Spatial Transcriptomics Service Revenue (US$ Million) by Type (2020 - 2031)

Figure 30. North America Spatial Transcriptomics Service Revenue (US$ Million) by Application (2020-2031)

Figure 31. US Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 32. Canada Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 33. Mexico Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 34. Europe Spatial Transcriptomics Service Revenue YoY (2020-2031) & (US$ Million)

Figure 35. Europe Top 5 Players Spatial Transcriptomics Service Revenue (US$ Million) in 2024

Figure 36. Europe Spatial Transcriptomics Service Revenue (US$ Million) by Type (2020-2031)

Figure 37. Europe Spatial Transcriptomics Service Revenue (US$ Million) by Application (2020-2031)

Figure 38. Germany Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 39. France Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 40. U.K. Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 41. Italy Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 42. Russia Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 43. Asia-Pacific Spatial Transcriptomics Service Revenue YoY (2020-2031) & (US$ Million)

Figure 44. Asia-Pacific Top 8 Players Spatial Transcriptomics Service Revenue (US$ Million) in 2024

Figure 45. Asia-Pacific Spatial Transcriptomics Service Revenue (US$ Million) by Type (2020-2031)

Figure 46. Asia-Pacific Spatial Transcriptomics Service Revenue (US$ Million) by Application (2020-2031)

Figure 47. Indonesia Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 48. Japan Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 49. South Korea Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 50. Australia Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 51. India Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 52. Indonesia Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 53. Vietnam Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 54. Malaysia Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 55. Philippines Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 56. Singapore Spatial Transcriptomics Service Revenue (2020-2031) & (US$ Million)

Figure 57. Central and South America Spatial Transcriptomics Service Revenue YoY (2020-2031) & (US$ Million)

Figure 58. Central and South America Top 5 Players Spatial Transcriptomics Service Revenue (US$ Million) in 2024

Figure 59. Central and South America Spatial Transcriptomics Service Revenue (US$ Million) by Type (2020-2031)

Figure 60. Central and South America Spatial Transcriptomics Service Revenue (US$ Million) by Application (2020-2031)

Figure 61. Brazil Spatial Transcriptomics Service Revenue (2020-2025) & (US$ Million)

Figure 62. Argentina Spatial Transcriptomics Service Revenue (2020-2025) & (US$ Million)

Figure 63. Middle East and Africa Spatial Transcriptomics Service Revenue YoY (2020-2031) & (US$ Million)

Figure 64. Middle East and Africa Top 5 Players Spatial Transcriptomics Service Revenue (US$ Million) in 2024

Figure 65. South America Spatial Transcriptomics Service Revenue (US$ Million) by Type (2020-2031)

Figure 66. Middle East and Africa Spatial Transcriptomics Service Revenue (US$ Million) by Application (2020-2031)

Figure 67. GCC Countries Spatial Transcriptomics Service Revenue (2020-2025) & (US$ Million)

Figure 68. Israel Spatial Transcriptomics Service Revenue (2020-2025) & (US$ Million)

Figure 69. Egypt Spatial Transcriptomics Service Revenue (2020-2025) & (US$ Million)

Figure 70. South Africa Spatial Transcriptomics Service Revenue (2020-2025) & (US$ Million)

Figure 71. Spatial Transcriptomics Service Industry Chain Mapping

Figure 72. Channels of Distribution (Direct Vs Distribution)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-29Y19622

Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Internet Intelligent Elderly Care Service Platform Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-25O19660

Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Spatial Epigenomics Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-4D20026

Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Plant Metabolomics Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-32Q19784

Thu Oct 02 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Spatial Transcriptomics Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-29Y19622

Global Spatial Transcriptomics Service Market Outlook, In‑Depth Analysis & Forecast to 2031

FEATURED COMPANIES

Spatial Transcriptomics Service Market Size

Spatial Transcriptomics Service Market

Report Includes:

Scope of Spatial Transcriptomics Service Market Report

Chapter Outline

FAQ for this report

How fast is Spatial Transcriptomics Service Market growing?

What is the Spatial Transcriptomics Service Market size in 2031?

Who are the main players in the Spatial Transcriptomics Service Market report?

What are the Application segmentation covered in the Spatial Transcriptomics Service Market report?

What are the Type segmentation covered in the Spatial Transcriptomics Service Market report?

FEATURED COMPANIES

RELATED REPORTS